Literature DB >> 30705695

Renin-angiotensin system in pre-eclampsia: everything old is new again.

Julia J Spaan1, Mark A Brown1.   

Abstract

This review presents an update of the role of the renin-angiotensin system in normal pregnancy and pre-eclampsia. We have known for years that the circulatory renin-angiotensin system in pre-eclampsia is suppressed. We now know that the circulating renin-angiotensin system does not only have a vasoconstrictor arm, but also a vasodilator arm, which is upregulated in normal pregnancy; this balance is probably disturbed in pre-eclampsia. Recent studies show the importance of the local renin-angiotensin system in the uteroplacental unit for early placentation and regulation of placental blood flow. We discuss the possible role of autoantibodies against the AT1-receptor in pre-eclampsia and the suggestion that activation of the AT1-receptor in the placenta may lead to placental dysfunction and the clinical syndrome of pre-eclampsia.

Entities:  

Keywords:  angiotensin; hypertension; physiology; placental insufficiency; pre-eclampsia; renin

Year:  2012        PMID: 30705695      PMCID: PMC6341511          DOI: 10.1258/om.2012.120007

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  84 in total

1.  The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy.

Authors:  A C Cooper; G Robinson; G P Vinson; W T Cheung; F Broughton Pipkin
Journal:  Placenta       Date:  1999 Jul-Aug       Impact factor: 3.481

2.  Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells.

Authors:  C Li; R Ansari; Z Yu; D Shah
Journal:  Hypertension       Date:  2000-08       Impact factor: 10.190

3.  Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation.

Authors:  G Valdés; A M Germain; J Corthorn; C Berrios; A C Foradori; C M Ferrario; K B Brosnihan
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

4.  The renin-aldosterone system during normal and hypertensive pregnancy.

Authors:  A Elsheikh; G Creatsas; G Mastorakos; S Milingos; D Loutradis; S Michalas
Journal:  Arch Gynecol Obstet       Date:  2001-01       Impact factor: 2.344

5.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

Authors:  G Wallukat; V Homuth; T Fischer; C Lindschau; B Horstkamp; A Jüpner; E Baur; E Nissen; K Vetter; D Neichel; J W Dudenhausen; H Haller; F C Luft
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Sequential changes in the renin--angiotensin--aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy.

Authors:  M H Weinberger; N J Kramer; L P Petersen; R E Cleary; P C Young
Journal:  Perspect Nephrol Hypertens       Date:  1976

7.  Angiotensin-(1-7) in normal and preeclamptic pregnancy.

Authors:  David C Merrill; Michael Karoly; Kai Chen; Carlos M Ferrario; K Bridget Brosnihan
Journal:  Endocrine       Date:  2002-08       Impact factor: 3.633

8.  Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness.

Authors:  S AbdAlla; H Lother; A el Massiery; U Quitterer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

9.  Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin.

Authors:  Genevieve Nguyen; Françoise Delarue; Céline Burcklé; Latifa Bouzhir; Thomas Giller; Jean-Daniel Sraer
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

10.  Prorenin concentration in the hypertensive disorders in pregnancy.

Authors:  R G de León; E M de Melián; A Coviello; E De Vito
Journal:  Hypertens Pregnancy       Date:  2001       Impact factor: 2.108

View more
  7 in total

1.  I/D Polymorphism Gene ACE and Risk of Preeclampsia in Women with Gestational Diabetes Mellitus.

Authors:  O P Dmitrenko; N S Karpova; M K Nurbekov; O V Papysheva
Journal:  Dis Markers       Date:  2020-12-28       Impact factor: 3.434

2.  STOX1 deficiency is associated with renin-mediated gestational hypertension and placental defects.

Authors:  Jacqueline G Parchem; Keizo Kanasaki; Soo Bong Lee; Megumi Kanasaki; Joyce L Yang; Yong Xu; Kadeshia M Earl; Rachel A Keuls; Vincent H Gattone; Raghu Kalluri
Journal:  JCI Insight       Date:  2021-01-25

3.  Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction.

Authors:  Siv Boon Mundal; Johanne Johnsen Rakner; Gabriela Brettas Silva; Lobke Marijn Gierman; Marie Austdal; Purusotam Basnet; Mattijs Elschot; Siril Skaret Bakke; Jenny Ostrop; Liv Cecilie Vestrheim Thomsen; Eric Keith Moses; Ganesh Acharya; Line Bjørge; Ann-Charlotte Iversen
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

Review 4.  Animal models of preeclampsia: investigating pathophysiology and therapeutic targets.

Authors:  Bhavisha A Bakrania; Eric M George; Joey P Granger
Journal:  Am J Obstet Gynecol       Date:  2021-03-12       Impact factor: 8.661

5.  Plane-Wave Ultrasound Doppler of the Eye in Preeclampsia.

Authors:  Ronald H Silverman; Raksha Urs; Ronald J Wapner; Srilaxmi Bearelly
Journal:  Transl Vis Sci Technol       Date:  2020-09-14       Impact factor: 3.283

6.  Placental Pathology as a Tool to Identify Women for Postpartum Cardiovascular Risk Screening following Preeclampsia: A Preliminary Investigation.

Authors:  Samantha J Benton; Erika E Mery; David Grynspan; Laura M Gaudet; Graeme N Smith; Shannon A Bainbridge
Journal:  J Clin Med       Date:  2022-03-13       Impact factor: 4.241

7.  Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.

Authors:  Alice M Jackson; Mark C Petrie; Alexandra Frogoudaki; Cécile Laroche; Finn Gustafsson; Bassem Ibrahim; Alexandre Mebazaa; Mark R Johnson; Petar M Seferovic; Vera Regitz-Zagrosek; Amam Mbakwem; Michael Böhm; Hawani S Prameswari; Doaa A Fouad; Sorel Goland; Albertino Damasceno; Kamilu Karaye; Hasan A Farhan; Righab Hamdan; Aldo P Maggioni; Karen Sliwa; Johann Bauersachs; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2021-08-25       Impact factor: 17.349

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.